French Experience with Buprenorphine : Do Physicians Follow the Guidelines?

Area of Science:

• Addiction Medicine
• Pharmacology
• Public Health

Background:

• Opiate dependence impacts over 15 million globally.
• Opiate substitution treatments (OST) are effective, with buprenorphine widely used in France.
• National guidelines for buprenorphine prescription have existed since 2004.

Purpose of the Study:

• To assess physician adherence to French buprenorphine prescription guidelines.
• To compare theoretical attitudes with actual clinical practices in buprenorphine prescribing.
• To identify factors influencing compliance with buprenorphine treatment protocols.

Main Methods:

• A questionnaire was emailed to a large sample of physicians (in practice, addiction networks, hospitals).
• Assessed physician knowledge and application of buprenorphine (BHD) prescribing guidelines.
• Analyzed prescribing data, including first-time prescriptions and patient follow-up.

Main Results:

• Physicians rarely incorporated guidelines into buprenorphine prescribing decisions.
• Prescribing practices for buprenorphine differed notably from national recommendations.
• Only 42% of independent Family Physicians (FPs) initiated buprenorphine, and 40% did not provide follow-up care.
• 55% of FPs provided theoretical responses only partially aligned with guidelines.

Conclusions:

• Significant discrepancies exist between French buprenorphine prescribing guidelines and actual physician practices.
• Adherence to guidelines varies based on physician affiliation (network vs. independent) and training status.
• Further interventions may be needed to improve guideline implementation in opiate substitution treatment.